Akademisyen

SEVİM DALVA AYDEMİR

ÖĞRETİM GÖREVLİSİ

ANKARA ÜNİVERSİTESİ BİYOTEKNOLOJİ ENSTİTÜSÜ BİYOTEKNOLOJİ ANABİLİM DALI

Ana Dal Fen Bilimleri ve Matematik Temel Alanı
Yan Dal Biyoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

Makale 6
Proje 0
Kitap 0
Bildiri 0
Patent 0
Sanatsal 0

Scopus (SJR) Q1 3 Q2 3 Q3 2 Q4 0

WoS (JCR) Q1 1 Q2 5 Q3 0 Q4 2

TR Index 0 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0

Üst %10 makale 0

Ort. yüzdelik 54.4%

Üst %1 payı 0.0%

Üst %10 payı 0.0%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Makale listesi

2022 Effect of CD34+ Total/Myeloid CD34+ Cell Progenitors and B-Lymphoid Progenitors Within the Bone Marrow Grafts on the Hematopoietic Recovery After Hematopoietic Stem Cell Transplantation Experimental and Clinical Transplantation DOI 10.6002/ect.2022.0210 YÖKSİS SJR Q3 JCR Q4 OpenAlex 22.5%
2021 Significance of inhibitory maternal killer-cell immunoglobulin-like receptor (KIR) and fetal KIR ligand genotype combinations in placenta related obstetric complications Journal of Reproductive Immunology DOI 10.1016/j.jri.2021.103425 YÖKSİS SJR Q1 JCR Q2 OpenAlex 46.3%
2019 Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor OMICS: A Journal of Integrative Biology DOI 10.1089/OMI.2019.0050 YÖKSİS SJR Q2 JCR Q2 OpenAlex 56.4%
2015 Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin LEUKEMIA & LYMPHOMA DOI 10.3109/10428194.2014.922180 YÖKSİS SJR Q2 JCR Q2 OpenAlex 82.3%
2015 Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin Clinical Cancer Research DOI 10.1158/1078-0432.CCR-14-1088 YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.3%
2013 AS160 Variant 2 Expression Enables Constitutive GLUT4 Plasma Membrane Localization and Elevated Glucose Consumption in Multiple Myeloma Cancer Metabolism DOI 10.1186/2049-3002-1-14 YÖKSİS OpenAlex 74.4%
2022 Effect of CD34+ Total/Myeloid CD34+ Cell Progenitors and B-Lymphoid Progenitors Within the Bone Marrow Grafts on the Hematopoietic Recovery After Hematopoietic Stem Cell Transplantation. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation DOI 10.6002/ect.2022.0210 YÖKSİS SJR Q3 JCR Q4 OpenAlex 22.5%
2021 Significance of inhibitory maternal killer-cell immunoglobulin-like receptor (KIR) and fetal KIR ligand genotype combinations in placenta related obstetric complications Journal of Reproductive Immunology DOI 10.1016/j.jri.2021.103425 YÖKSİS SJR Q1 JCR Q2 OpenAlex 46.3%
2019 Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor OMICS: A Journal of Integrative Biology DOI 10.1089/omi.2019.0050 YÖKSİS SJR Q2 JCR Q2 OpenAlex 56.4%

Akademisyenlere dön